Woojung Bio (XKRX:215380) Accounts Payable & Accrued Expense : ₩3,504 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Woojung Bio Accounts Payable & Accrued Expense?

Woojung Bio's quarterly accounts payable & accrued expense increased from Jun. 2023 (₩2,212 Mil) to Sep. 2023 (₩3,678 Mil) but then declined from Sep. 2023 (₩3,678 Mil) to Dec. 2023 (₩3,504 Mil).

Woojung Bio's annual accounts payable & accrued expense declined from Dec. 2021 (₩3,999 Mil) to Dec. 2022 (₩2,979 Mil) but then increased from Dec. 2022 (₩2,979 Mil) to Dec. 2023 (₩3,504 Mil).

Woojung Bio Accounts Payable & Accrued Expense Historical Data

The historical data trend for Woojung Bio's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Woojung Bio Accounts Payable & Accrued Expense Chart

Woojung Bio Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

6,538.59

2,175.42

3,998.83

2,979.05

3,503.60

Woojung Bio Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															2,979.05	1,920.62	2,211.66	3,677.64	3,503.60

Woojung Bio Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Woojung Bio (XKRX:215380) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Woojung Bio Inc (XKRX:215380) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Gwanggyo-ro 145, B-dong 3rd Floor, Next Generation Convergence Technology Research Center, Gyeonggi-do, Yeongtong-gu, Suwon-si, KOR

Website

http://bio.woojungbsc.co.kr

Woojung Bio Inc is engaged in the research and development of natural science and engineering. Its products include Gene Delivery, Antibody Production, Immunodeficiency model, Human-to-human model, Zika, Mers, Dengue, Influenza Virus Research, Influenza virus, vaccine studies, and Elegant Goettingen Mini Pig.

Woojung Bio (XKRX:215380) Headlines

No Headlines